Journal of Clinical Medicine (Oct 2021)

Carotid Artery Temperature Reduction with Statin Therapy in Patients with Familial Hyperlipidemia Syndromes

  • Georgios Benetos,
  • Spyros Galanakos,
  • Iosif Koutagiar,
  • Ioannis Skoumas,
  • Georgios Oikonomou,
  • Maria Drakopoulou,
  • Maria Karmpalioti,
  • Vasiliki Katsi,
  • Costas Tsioufis,
  • Konstantinos Toutouzas

DOI
https://doi.org/10.3390/jcm10215008
Journal volume & issue
Vol. 10, no. 21
p. 5008

Abstract

Read online

Background: Microwave radiometry (MWR) assesses non-invasive carotid artery temperatures reflecting inflammation. In the present study, we aimed to investigate the impact of hypolipidemic therapy either with simvastatin or with combination simvastatin plus ezetimibe on carotid artery temperatures of patients with familial hyperlipidemia syndromes (FHS). Methods: Consecutive patients with diagnosis of either familial heterozygous hypercholesterolemia (heFH) or familial combined hyperlipidemia (FCH) were included in the study. Patients were assigned to either simvastatin 40 mg or simvastatin 40 mg plus ezetimibe 10 mg, according to the discretion of the physician. FHS patients who refused statin therapy were used as a control group. Common carotid intima-media thickness (ccIMT) was measured and ΔΤ (maximum-minimum) temperature measurements were performed across each carotid during MWR evaluation. RESULTS: In total, 115 patients were included in the study. Of them, 40 patients received simvastatin (19 heFH and 21 FCH), 41 simvastatin + ezetimibe (31 heFH and 10 FCH), and 34 (21 heFH and 13 FCH) no statin. Carotid artery temperatures were significantly reduced at 6 months in FH patients who received hypolipidemic treatment (0.83 ± 0.34 versus 0.63 ± 0.24 °C, p = 0.004 for simvastatin, 1.00 ± 0.38 versus 0.69 ± 0.23 °C, p p = 0.86). Conclusions: Hypolipidemic therapy reduced carotid temperatures in FHS patients.

Keywords